Anim Biosci > Volume 30(3); 2017 > Article |
|
AFLP, amplified fragment length polymorphism; ANKRD16, ankyrin repeat domain 16; CYP24A1, cytochrome P450 family 24 subfamily A member 1; DOK5, docking protein 5; GUCY1B3, guanylate cyclase 1 soluble beta 3; OR51V1, olfactory receptor family 51, subfamily V, member 1; RREB1, ras responsive element binding protein 1.
SNP | N | Genotype frequency | Allele frequency | |||
---|---|---|---|---|---|---|
|
|
|||||
AA | AB | BB | A1) | B | ||
SSC7 g.4937240C>G | 565 | 0.48 | 0.36 | 0.16 | 0.65 | 0.35 |
SSC8 g.47338181G>A | 513 | 0.64 | 0.24 | 0.12 | 0.76 | 0.24 |
SSC9 g.5496647_5496662insdel | 585 | 0.28 | 0.58 | 0.14 | 0.57 | 0.43 |
SSC10 g.71225134G>A | 601 | 0.81 | 0.19 | 0.00 | 0.90 | 0.10 |
SSC17 g.61976696G>T | 570 | 0.52 | 0.30 | 0.18 | 0.67 | 0.33 |
1) Allele A represents major alleles of the SSC7 g.4937240C, SSC8 g.47338181A, SSC9 g.5496647_5496662del, SSC10 g.71225134A and SSC17 g.61976696G loci, respectively and allele B represents minor alleles of the SSC7 g.4937240G, SSC8 g.47338181G, SSC9 g.5496647_5496662ins, SSC10 g.71225134G and SSC17 g.61976696T loci, respectively.
Traits (%) | Genotypes (Least squares mean±standard error) | p-value | ||
---|---|---|---|---|
|
||||
CC (n = 180) | CG (n = 129) | GG (n = 63) | ||
IMF | 2.628±0.170b | 2.364±0.177a | 2.212±0.258a | 0.0454 |
C14:0 (Myristic) | 1.175±0.062 | 1.020±0.072 | 1.074±0.127 | 0.1241 |
C16:0 (Palmitic) | 13.605±1.049 | 11.539±1.221 | 12.498±2.131 | 0.2944 |
C18:0 (Stearic) | 12.366±0.897 | 10.827±1.044 | 10.999±1.823 | 0.3275 |
C20:0 (Arachidic) | 0.303±0.067 | 0.278±0.078 | 0.187±0.136 | 0.7342 |
SFA | 24.451±1.429 | 23.666±1.663 | 25.759±2.903 | 0.1074 |
C16:1n-9 (Palmitoleic) | 3.957±0.320 | 3.534±0.373 | 4.433±0.651 | 0.4641 |
C18:1n-9 (Oleic) | 32.675±1.924 | 32.657±2.239 | 31.358±3.909 | 0.9581 |
C20:1n-9 (Eicosenoic) | 2.394±0.403 | 2.237±0.469 | 1.559±0.820 | 0.6521 |
MUFA | 39.027±1.960 | 38.429±2.281 | 37.351±3.981 | 0.9093 |
C18:2n-6 (Linoleic) | 24.373±1.592 | 26.243±1.852 | 27.504±3.234 | 0.1572 |
C18:3n-6 (Linolenic) | 0.124±0.044 | 0.155±0.051 | 0.145±0.090 | 0.8318 |
C20:2n-6 (Eicosadienoic) | 1.682±0.251 | 1.548±0.292 | 1.925±0.509 | 0.8332 |
C20:3n-6 (Homolinolenic) | 0.142±0.050 | 0.274±0.058 | 0.185±0.102 | 0.1097 |
C20:4n-6 (Arachidonic) | 0.166±0.119 | 0.224±0.139 | 0.232±0.143 | 0.3448 |
PUFA | 26.489±1.610 | 28.447±1.873 | 29.429±2.270 | 0.1637 |
ω3 FA | 1.311±0.263 | 1.539±0.306 | 1.473±0.535 | 0.2251 |
ω6 FA | 24.993±1.651 | 27.031±1.921 | 27.004±1.353 | 0.1657 |
ω9 FA | 36.633±1.944 | 36.192±2.261 | 37.792±3.948 | 0.9673 |
IMF, intramuscular fat content; SFA, saturated fatty acids (C14:0+C16:0+C18:0+C20:0); MUFA, monounsaturated fatty acids (C16:1n-9+C18:1n-9+C20:1n-9); PUFA, polyunsaturated fatty acids (C18:2n-6+C18:3n-6+C20:2n-6+C20:3n-6+C20:4n-6); ω3 fatty acids (C18:3n-3+C20:5n-3+C22:6n-3); ω6 fatty acids (C18:2n-6+C18:3n-6+C20:3n-6); ω9 fatty acids (C16:1n-9+C18:1n-9).
Traits (%) | Genotypes (Least squares mean±standard error) | p-value | ||
---|---|---|---|---|
|
||||
InsIns (n = 55) | InsDel (n = 230) | DelDel (n = 105) | ||
IMF | 1.716±0.269a | 2.648±0.159a | 2.526±0.304b | 0.0155 |
C14:0 (Myristic) | 1.150±0.243 | 1.096±0.073 | 1.025±0.103 | 0.7189 |
C16:0 (Palmitic) | 13.729±3.503 | 13.287±1.054 | 11.538±1.487 | 0.4236 |
C18:0 (Stearic) | 10.347±2.861 | 12.200±0.861 | 12.427±1.215 | 0.8258 |
C20:0 (Arachidic) | 0.380±0.213 | 0.348±0.064 | 0.326±0.090 | 0.5580 |
SFA | 25.307±4.809 | 26.933±1.448 | 25.316±2.042 | 0.6706 |
C16:1n-9 (Palmitoleic) | 5.429±1.107 | 3.837±0.333 | 3.467±0.470 | 0.2907 |
C18:1n-9 (Oleic) | 34.674±3.855 | 34.279±1.763 | 33.626±2.486 | 0.9379 |
C20:1n-9 (Eicosenoic) | 1.646±1.075 | 2.424±0.384 | 1.829±0.541 | 0.3757 |
MUFA | 39.224±4.899 | 40.541±1.776 | 38.924±2.505 | 0.7707 |
C18:2n-6 (Linoleic) | 22.838±3.009 | 22.644±1.508 | 24.971±2.127 | 0.3214 |
C18:3n-6 (Linolenic) | 0.158±0.138 | 0.113±0.041 | 0.68±0.058 | 0.5761 |
C20:2n-6 (Eicosadienoic) | 1.267±0.804 | 1.687±0.242 | 1.513±0.341 | 0.7911 |
C20:3n-6 (Homolinolenic) | 0.139±0.168 | 0.179±0.050 | 0.243±0.071 | 0.4402 |
C20:4n-6 (Arachidonic) | 0.145±0.115a | 0.150±0.105a | 0.453±0.149b | 0.0282 |
PUFA | 27.864±3.033 | 24.774±1.515 | 27.350±2.137 | 0.3266 |
ω3 FA | 1.395±0.842 | 1.134±0.253 | 1.291±0.357 | 0.8691 |
ω6 FA | 25.380±3.185 | 23.250±1.561 | 25.644±2.201 | 0.3371 |
ω9 FA | 39.077±4.933 | 38.116±1.786 | 37.094±2.519 | 0.9032 |
IMF, intramuscular fat content; SFA, saturated fatty acids (C14:0+C16:0+C18:0+C20:0); MUFA, monounsaturated fatty acids (C16:1n-9+C18:1n-9+C20:1n-9); PUFA, polyunsaturated fatty acids (C18:2n-6+C18:3n-6+C20:2n-6+C20:3n-6+C20:4n-6); ω3 fatty acids (C18:3n-3+C20:5n-3+C22:6n-3); ω6 fatty acids (C18:2n-6+C18:3n-6+C20:3n-6); ω9 fatty acids (C16:1n-9+C18:1n-9).
Traits (%) | Genotypes (Least squares mean±standard error) | p-value | |
---|---|---|---|
|
|||
AA (n =198) | AG (n = 57) | ||
IMF | 2.287±0.121 | 2.397±0.282 | 0.7155 |
C14:0 (Myristic) | 1.085±0.050 | 1.208±0.171 | 0.2614 |
C16:0 (Palmitic) | 13.084±0.811 | 11.539±2.333 | 0.5121 |
C18:0 (Stearic) | 11.384±0.646 | 13.692±1.858 | 0.2224 |
C20:0 (Arachidic) | 0.263±0.048 | 0.323±0.140 | 0.6680 |
SFA | 25.819±1.127 | 26.834±3.302 | 0.7210 |
C16:1n-9 (Palmitoleic) | 3.860±0.243a | 5.323±0.699b | 0.0440 |
C18:1n-9 (Oleic) | 34.576±0.919 | 36.785±2.366 | 0.3480 |
C20:1n-9 (Eicosenoic) | 2.010±0.225 | 1.581±0.648 | 0.5126 |
MUFA | 40.160±1.045 | 44.119±2.692 | 0.1436 |
C18:2n-6 (Linoleic) | 25.510±1.213 | 22.110±3.491 | 0.3364 |
C18:3n-6 (Linolenic) | 0.135±0.031 | 0.134±0.092 | 0.9963 |
C20:2n-6 (Eicosadienoic) | 1.689±0.180 | 1.163±0.517 | 0.3170 |
C20:3n-6 (Homolinolenic) | 0.181±0.038 | 0.089±0.110 | 0.4101 |
C20:4n-6 (Arachidonic) | 0.115±0.089 | 0.034±0.257 | 0.7549 |
PUFA | 27.632±1.227 | 23.532±3.529 | 0.2531 |
ω3 FA | 1.294±0.177 | 0.907±0.603 | 0.5257 |
ω6 FA | 26.155±1.257 | 23.634±3.617 | 0.3368 |
ω9 FA | 35.992±1.291a | 44.322±3.655b | 0.0284 |
IMF, intramuscular fat content; SFA, saturated fatty acids (C14:0+C16:0+C18:0+C20:0); MUFA, monounsaturated fatty acids (C16:1n-9+C18:1n-9+C20:1n-9); PUFA, polyunsaturated fatty acids (C18:2n-6+C18:3n-6+C20:2n-6+C20:3n-6+C20:4n-6); ω3 fatty acids (C18:3n-3+C20:5n-3+C22:6n-3); ω6 fatty acids (C18:2n-6+C18:3n-6+C20:3n-6); ω9 fatty acids (C16:1n-9+C18:1n-9).
Traits (%) | Genotypes (Least squares mean±standard error) | p-value | ||
---|---|---|---|---|
|
||||
GG (n = 175) | GT (n = 127) | TT (n = 52) | ||
IMF | 2.104±0.128a | 2.594±0.195b | 2.172±0.335ab | 0.0451 |
C14:0 (Myristic) | 1.123±0.068 | 1.020±0.086 | 1.035±0.127 | 0.5482 |
C16:0 (Palmitic) | 13.107±1.013 | 12.797±1.270 | 11.354±1.875 | 0.6481 |
C18:0 (Stearic) | 11.768±0.812 | 12.327±1.019 | 10.808±1.054 | 0.6829 |
C20:0 (Arachidic) | 0.301± 0.062 | 0.291±0.078 | 0.321±0.115 | 0.9702 |
SFA | 26.301±1.373 | 26.437±1.722 | 23.519±2.542 | 0.2927 |
C16:1n-9 (Palmitoleic) | 4.250±0.246b | 3.008±0.309a | 3.175±0.356a | 0.0153 |
C18:1n-9 (Oleic) | 37.334±1.145 | 34.459±1.436 | 38.881±2.120 | 0.0967 |
C20:1n-9 (Eicosenoic) | 2.322±0.372b | 1.726±0.467a | 1.846±0.489a | 0.0491 |
MUFA | 43.906±1.278b | 39.194±1.603a | 38.904±1.565a | 0.0255 |
C18:2n-6 (Linoleic) | 22.760±1.523 | 22.848±1.910 | 23.422±2.819 | 0.9722 |
C18:3n-6 (Linolenic) | 0.145±0.039 | 0.107±0.049 | 0.210±0.073 | 0.4165 |
C20:2n-6 (Eicosadienoic) | 1.596±0.224 | 1.403±0.281 | 1.242±0.415 | 0.6608 |
C20:3n-6 (Homolinolenic) | 0.127±0.047 | 0.210±0.059 | 0.288±0.088 | 0.1730 |
C20:4n-6 (Arachidonic) | 0.125±0.014a | 0.285±0.011b | 0.120±0.021a | 0.0432 |
PUFA | 24.655±1.538 | 24.756±1.929 | 25.370±2.847 | 0.9684 |
ω3 FA | 1.164±0.254 | 1.100±0.319 | 1.201±0.234 | 0.7431 |
ω6 FA | 23.297±1.575 | 23.377±1.975 | 24.200±2.915 | 0.9510 |
ω9 FA | 41.584±1.274b | 37.468±1.598a | 37.638±1.859a | 0.0472 |
IMF, intramuscular fat content; SFA, saturated fatty acids (C14:0+C16:0+C18:0+C20:0); MUFA, monounsaturated fatty acids (C16:1n-9+C18:1n-9+C20:1n-9); PUFA, polyunsaturated fatty acids (C18:2n-6+C18:3n-6+C20:2n-6+C20:3n-6+C20:4n-6); ω3 fatty acids (C18:3n-3+C20:5n-3+C22:6n-3); ω6 fatty acids (C18:2n-6+C18:3n-6+C20:3n-6); ω9 fatty acids (C16:1n-9+C18:1n-9).